Cargando…

Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI

Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present. They can also be used to label targeted molecular imaging probes. Unfortunately, no molecular imaging probe is currently available on the clinical MRI market. A promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodhia, J, Mandarano, G, Ferris, NJ, Eu, P, Cowell, SF
Formato: Texto
Lenguaje:English
Publicado: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097763/
https://www.ncbi.nlm.nih.gov/pubmed/21611034
http://dx.doi.org/10.2349/biij.6.2.e12
_version_ 1782203886352728064
author Lodhia, J
Mandarano, G
Ferris, NJ
Eu, P
Cowell, SF
author_facet Lodhia, J
Mandarano, G
Ferris, NJ
Eu, P
Cowell, SF
author_sort Lodhia, J
collection PubMed
description Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present. They can also be used to label targeted molecular imaging probes. Unfortunately, no molecular imaging probe is currently available on the clinical MRI market. A promising platform for MRI contrast agent development is nanotechnology, where superparamagnetic iron oxide nanoparticles (SPIONS) are tailored for MR contrast enhancement, and/or for molecular imaging. SPIONs can be produced using a range of methods and the choice of method will be influenced by the characteristics most important for a particular application. In addition, the ability to attach molecular markers to SPIONS heralds their application in molecular imaging. There are many reviews on SPION synthesis for MRI; however, these tend to be targeted to a chemistry audience. The development of MRI contrast agents attracts experienced researchers from many fields including some researchers with little knowledge of medical imaging or MRI. This situation presents medical radiation practitioners with opportunities for involvement, collaboration or leadership in research depending on their level of commitment and their ability to learn. Medical radiation practitioners already possess a large portion of the understanding, knowledge and skills necessary for involvement in MRI development and molecular imaging. Their expertise in imaging technology, patient care and radiation safety provides them with skills that are directly applicable to research on the development and application of SPIONs and MRI. In this paper we argue that MRI SPIONs, currently limited to major research centres, will have widespread clinical use in the future. We believe that knowledge about this growing area of research provides an opportunity for medical radiation practitioners to enhance their specialised expertise to ensure best practice in a truly multi-disciplinary environment. This review outlines how and why SPIONs can be synthesised and examines their characteristics and limitations in the context of MR imaging.
format Text
id pubmed-3097763
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
record_format MEDLINE/PubMed
spelling pubmed-30977632011-05-24 Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI Lodhia, J Mandarano, G Ferris, NJ Eu, P Cowell, SF Biomed Imaging Interv J Review Article Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present. They can also be used to label targeted molecular imaging probes. Unfortunately, no molecular imaging probe is currently available on the clinical MRI market. A promising platform for MRI contrast agent development is nanotechnology, where superparamagnetic iron oxide nanoparticles (SPIONS) are tailored for MR contrast enhancement, and/or for molecular imaging. SPIONs can be produced using a range of methods and the choice of method will be influenced by the characteristics most important for a particular application. In addition, the ability to attach molecular markers to SPIONS heralds their application in molecular imaging. There are many reviews on SPION synthesis for MRI; however, these tend to be targeted to a chemistry audience. The development of MRI contrast agents attracts experienced researchers from many fields including some researchers with little knowledge of medical imaging or MRI. This situation presents medical radiation practitioners with opportunities for involvement, collaboration or leadership in research depending on their level of commitment and their ability to learn. Medical radiation practitioners already possess a large portion of the understanding, knowledge and skills necessary for involvement in MRI development and molecular imaging. Their expertise in imaging technology, patient care and radiation safety provides them with skills that are directly applicable to research on the development and application of SPIONs and MRI. In this paper we argue that MRI SPIONs, currently limited to major research centres, will have widespread clinical use in the future. We believe that knowledge about this growing area of research provides an opportunity for medical radiation practitioners to enhance their specialised expertise to ensure best practice in a truly multi-disciplinary environment. This review outlines how and why SPIONs can be synthesised and examines their characteristics and limitations in the context of MR imaging. Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2010-04-01 /pmc/articles/PMC3097763/ /pubmed/21611034 http://dx.doi.org/10.2349/biij.6.2.e12 Text en © 2010 Biomedical Imaging and Intervention Journal http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lodhia, J
Mandarano, G
Ferris, NJ
Eu, P
Cowell, SF
Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
title Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
title_full Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
title_fullStr Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
title_full_unstemmed Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
title_short Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
title_sort development and use of iron oxide nanoparticles (part 1): synthesis of iron oxide nanoparticles for mri
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097763/
https://www.ncbi.nlm.nih.gov/pubmed/21611034
http://dx.doi.org/10.2349/biij.6.2.e12
work_keys_str_mv AT lodhiaj developmentanduseofironoxidenanoparticlespart1synthesisofironoxidenanoparticlesformri
AT mandaranog developmentanduseofironoxidenanoparticlespart1synthesisofironoxidenanoparticlesformri
AT ferrisnj developmentanduseofironoxidenanoparticlespart1synthesisofironoxidenanoparticlesformri
AT eup developmentanduseofironoxidenanoparticlespart1synthesisofironoxidenanoparticlesformri
AT cowellsf developmentanduseofironoxidenanoparticlespart1synthesisofironoxidenanoparticlesformri